Topical lidocaine has been recently marketed as a new treatment for postherpetic neuralgia. The aim of our study was to characterize the absorption profile of and systemic exposure to lidocaine from patch and gel formulations in normal volunteers, patients with post-herpetic neuralgia, and patients
Assessment of transcriptomal analysis of varicella-zoster-virus gene expression in patients with and without post-herpetic neuralgia
β Scribed by G. H. Ashrafi; Esther Grinfeld; Paul Montague; Thorsten Forster; Alan Ross; Peter Ghazal; Fiona Scott; Judith Breuer; Roslyn Goodwin; Peter G. E. Kennedy
- Book ID
- 106558770
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 310 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0920-8569
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Little is known about reactivation of latent varicella zoster virus as herpes zoster in individuals with no underlying immunosuppression. Risk factors include age, sex, ethnicity, exogenous boosting of immunity from varicella contacts, underlying cellβmediated immune disorders, mechanic
Varicella-zoster virus (VZV) reactivation without cutaneous vesicles (zoster sine herpete) has been demonstrated in 8 to 25% of patients with acute peripheral facial palsy (APFP) by serological methods. To make an early diagnosis of zoster sine herpete, VZV DNA in oropharyngeal swabs from patients w